<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04067440</url>
  </required_header>
  <id_info>
    <org_study_id>METABIOM</org_study_id>
    <nct_id>NCT04067440</nct_id>
  </id_info>
  <brief_title>Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and Stool</brief_title>
  <acronym>METABIOM</acronym>
  <official_title>Characterization and Comparison of the Human Microbiome in Peritoneum, Jejunum, Rectum and Stool</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Saarland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Saarland University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Saarland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Characterization of the human microbiome in the jejunum and comparison to the microbiome in
      the rectum and stool in order to see how the microbial communities change within the
      intestines.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects to undergo surgery with opening of the jejunum will be sampled with sterile swabs
      from peritoneum and the inside of the jejunum. A swab will also be taken from the rectum.

      The peritoneum is regarded as a sterile place until today. We try to either verify this, we
      also could find a scientific base for theories like leaky gut or other forms of bacterial
      migration through the intestinal wall.

      Many of these patients undergo bariatric surgery. Many of them do have a dramatic change in
      glucose metabolism immediate after surgery. Therefore stool swabs will be taken before and 5
      days after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2019</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Characterization of microbiome</measure>
    <time_frame>intra-operative</time_frame>
    <description>Previously uncharacterized sites: jejunum, peritoneum</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Obesity</condition>
  <condition>Diabetes Mellitus</condition>
  <condition>Fatty Liver, Nonalcoholic</condition>
  <condition>Leaky Gut Syndrome</condition>
  <condition>Chronic Pancreatitis</condition>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
    <description>Subjects to undergo surgery including opening of the jejunum with non-inflammative condition.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Microbial Swab</intervention_name>
    <description>Swabs will be taken from peritoneum and jejunum (intraoperatively), rectum, and stool</description>
    <arm_group_label>Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with obesity
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  abdominal surgery containing opening of jejunum

          -  singing of consent

        Exclusion Criteria:

          -  inflammative condition (appendicitis, pancreatitis, Crohn, Colitis ulcerous,
             cholecystitis and similar)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Jelden, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saarland University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Jelden, Dr.</last_name>
    <phone>+49684116</phone>
    <phone_ext>30000</phone_ext>
    <email>michael.jelden@uks.eu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of General, Visceral, Vascular and Pediatric Surgery, University of Saarland,</name>
      <address>
        <city>Homburg/Saar</city>
        <zip>D-66421</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Jelden, M.D., FRCS</last_name>
      <phone>+4968411631000</phone>
      <email>michael.jelden@uks.eu</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>August 21, 2019</study_first_submitted>
  <study_first_submitted_qc>August 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 26, 2019</study_first_posted>
  <last_update_submitted>October 2, 2019</last_update_submitted>
  <last_update_submitted_qc>October 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Saarland</investigator_affiliation>
    <investigator_full_name>Michael Jelden, MD</investigator_full_name>
    <investigator_title>Dr. med. Michael Jelden</investigator_title>
  </responsible_party>
  <keyword>Microbiome</keyword>
  <keyword>Obesity</keyword>
  <keyword>Chronic Liver Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Pancreatitis, Chronic</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

